GNPXNasdaq · Pharmaceutical Preparations

Genprex, Inc.

Alert me on GNPX

Insider buys, 6 months

Congress trades, 6 months

Signals, 6 months

Six months

After each filing

Apr 16 Sale LONGNECKER BRENT M Insider

1 week

−21.5%S&P +1.0%

1 month

−36.1%S&P +5.3%

3 months

−73.2%S&P +6.2%

6 months

−92.0%S&P +10.5%

Feb 20 Buy Rep. Tim Moore House

1 week

−12.3%S&P +0.6%

1 month

−16.7%S&P −4.0%

3 months

−63.8%S&P +9.6%

6 months

−92.0%S&P +12.5%

Jan 7 Buy Rep. Tim Moore House

1 week

+65.0%S&P +0.4%

1 month

+10.0%S&P +0.6%

3 months

−42.5%S&P −1.2%

6 months

−73.2%S&P +9.2%

Dec 2, 2025 Buy Rep. Tim Moore House

1 week

+17.7%S&P +0.5%

1 month

−36.4%S&P +0.9%

3 months

−31.1%S&P −1.4%

6 months

−77.1%S&P +8.5%

Nov 12, 2025 Buy Rep. Tim Moore House

1 week

−23.7%S&P −2.9%

1 month

−37.7%S&P +1.3%

3 months

−56.5%S&P +1.9%

6 months

−80.6%S&P +10.5%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for GNPX

15 held · newest 515 held · newest 2

Loading the filings.

See all 15 filings for GNPX

Aeon news and offers by email

New sources, new features and offers like our founding price. A few times a month at most. Stop any time.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal

No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters

No lobbying reports on file.